Axsome Therapeutics, Inc. Earnings

Axsome Therapeutics, Inc.’s revenue jumped 65.03% since last year same period to $196Mn in the Q4 2025. On a quarterly growth basis, Axsome Therapeutics, Inc. has generated 14.62% jump in its revenue since last 3-months.

Axsome Therapeutics, Inc.’s net profit jumped 61.88% since last year same period to $-28.56Mn in the Q4 2025. On a quarterly growth basis, Axsome Therapeutics, Inc. has generated 39.53% jump in its net profits since last 3-months.

Axsome Therapeutics, Inc.’s net profit margin jumped 76.9% since last year same period to -14.57% in the Q4 2025. On a quarterly growth basis, Axsome Therapeutics, Inc. has generated 47.25% jump in its net profit margins since last 3-months.

Axsome Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.65 - a 10.38% jump from last quarter’s estimates.

Axsome Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.65.

Axsome Therapeutics, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Axsome Therapeutics, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.